Patents by Inventor Noboru Sekiya

Noboru Sekiya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TABLET COMPRISING OPICAPONE
    Publication number: 20230181474
    Abstract: The present invention provides a tablet comprising opicapone or a pharmaceutically acceptable salt thereof, having reduced tableting faults during manufacture.
    Type: Application
    Filed: May 26, 2021
    Publication date: June 15, 2023
    Inventors: Koji Taniguchi, Noboru Sekiya, Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima
  • Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino] pyrimidine trihydrochloride as active ingredient
    Patent number: 7041317
    Abstract: A sustained-release formulation of 5-acetyl-4,6-dimethyl-2-[2-[4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride coated with a release-controlling film comprising a water-insoluble polymer film having no hydrophilic group. The formulation of the present invention has such a release pattern that the drug release lasts for 20 hours or more, so that can be appropriately administered for treatment. Furthermore, the formulation itself is so stable that its release pattern does not change with pH and the formulation does not suffer from deterioration, coloration and the like with the lapse of time.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: May 9, 2006
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Noboru Sekiya, Yoshinori Ii, Masayuki Ishikawa, Hiroshi Azuma
  • Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
    Publication number: 20050101606
    Abstract: A sustained-release formulation of 5-acetyl-4,6-dimethyl-2-[2-[4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride coated with a release-controlling film comprising a water-insoluble polymer film having no hydrophilic group. The formulation of the present invention has such a release pattern that the drug release lasts for 20 hours or more, so that can be appropriately administered for treatment. Furthermore, the formulation itself is so stable that its release pattern does not change with pH and the formulation does not suffer from deterioration, coloration and the like with the lapse of time.
    Type: Application
    Filed: October 22, 2001
    Publication date: May 12, 2005
    Inventors: Noboru Sekiya, Yoshinori Ii, Masayuki Ishikawa, Hiroshi Azuma